Literature DB >> 17364369

Thymidine phosphorylase mRNA level predicts survival of patients with advanced oropharyngeal cancer.

Takahiro Ijuin1, Ken-ichi Nibu, Kiyoshi Doi, Hiroyuki Inoue, Miki Saitoh, Naoki Ohtsuki, Kunihiko Makino, Mutsuo Amatsu.   

Abstract

CONCLUSION: The present study suggested that a high level of thymidine phosphorylase (TP) gene expression is significantly associated with favorable prognosis of patients treated with 5-fluorouracil (5-FU)-based chemotherapy. Further studies consisting of large series should be performed to confirm our present results.
BACKGROUND: Expression levels of the thymidylate synthase (TS) and 5-FU metabolic enzymes including dihydropyrimidine dehydrogenase (DPD), TP, and orotate phosphoribosyl transferase (OPRT), are reported to be associated with sensitivity to 5-FU-based chemotherapy in several cancers. PATIENTS AND METHODS: Intratumoral mRNA expression levels of TS, DPD, TP, and OPRT in pretreatment biopsy specimens were quantified in 27 patients with advanced oropharyngeal squamous cell carcinomas. Association of these expression levels with response to platinum and 5-FU-based chemotherapy and survival were analyzed statistically.
RESULTS: By Spearman's correlation analysis, significant correlation was observed between TS and TP (gamma=0.51, p=0.018). While no correlation was observed between the tumor regression and expression of any of the genes investigated, significant association was observed between prognosis and mRNA expression levels of TS and TP. Multivariate Cox regression analysis revealed that TP mRNA expression level is a significant factor predicting prognosis (hazard ratio (HR) = - 0.204, p=0.043).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17364369     DOI: 10.1080/00016480600801381

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  2 in total

1.  Thymidylate synthase and thymidine phosphorylase gene expression as predictive parameters for the efficacy of 5-fluorouracil-based adjuvant chemotherapy for gastric cancer.

Authors:  Dong Hua; Zhao-Hui Huang; Yong Mao; Jian-Zhong Deng
Journal:  World J Gastroenterol       Date:  2007-10-07       Impact factor: 5.742

2.  Evaluation of pemetrexed and etoposide as therapeutic regimens for human papillomavirus-positive oral and oropharyngeal cancer.

Authors:  Yi Rang Kim; Bada Lee; Mi Ran Byun; Jong Kil Lee; Jin Woo Choi
Journal:  PLoS One       Date:  2018-07-11       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.